E
M. Mamone et al.
Paper
Synthesis
HRMS (ESI): m/z [M + H+] calcd for C17H15N2O2: 279.1134; found:
279.1125.
1H NMR (300 MHz, MeOH-d4): δ = 9.08 (d, J = 1.6 Hz, 1 H), 8.73 (dd,
J = 4.9, 1.4 Hz, 1 H), 8.38–8.32 (m, 1 H), 7.71–7.64 (m, 2 H), 7.59 (dd,
J = 7.5, 5.0 Hz, 1 H), 7.56–7.48 (m, 2 H).
13C NMR (75 MHz, MeOH-d4): δ = 166.3, 152.9, 149.4, 138.9, 137.2,
N-(4-Methoxyphenyl)quinoline-6-carboxamide (7)
132.8, 132.5, 125.1, 123.8, 118.3.
Starting from 6-bromoquinoline (132 mg, 0.63 mmol), flash chroma-
MS (ES+): m/z (%) = 279 (100) [M + 2 H]+.
tography afforded 7 (128 mg, 73%) as a white solid; mp 194 °C.
1H NMR (300 MHz, DMSO-d6): δ = 10.41 (s, 1 H), 9.01 (dd, J = 4.0, 1.3
Hz, 1 H), 8.62 (d, J = 1.1 Hz, 1 H), 8.53 (d, J = 8.1 Hz, 1 H), 8.27 (dd,
J = 8.8, 1.6 Hz, 1 H), 8.13 (d, J = 8.8 Hz, 1 H), 7.79–7.70 (m, 2 H), 7.63
(dd, J = 8.3, 4.2 Hz, 1 H), 7.01–6.90 (m, 2 H), 3.76 (s, 3 H).
13C NMR (75 MHz, DMSO-d6): δ = 164.7 and 164.6, 155.7, 152.2,
148.8, 137.2, 132.9 and 132.9, 132.2 and 132.1, 129.1, 128.3, 128.1,
127.1, 122.3, 122.0 and 121.9, 113.8, 55.2.
HRMS (ESI): m/z [M + H+] calcd for C12H10N2OBr: 276.9976; found:
276.9983.
N-(2,5-Difluorophenyl)nicotinamide (15)
Starting from 3-bromopyridine (100 mg, 0.63 mmol), flash chroma-
tography afforded 13 (121 mg, 81%) as a white solid; mp 146 °C.
1H NMR (300 MHz, MeOH-d4): δ = 9.09 (d, J = 1.7 Hz, 1 H), 8.74 (dd,
J = 4.9, 1.5 Hz, 1 H), 8.37–8.32 (m, 1 H), 7.76 (ddd, J = 9.5, 6.0, 3.2 Hz, 1
H), 7.59 (dd, J = 7.9, 5.0 Hz, 1 H), 7.11 (dt, J = 9.6, 4.9 Hz, 1 H), 7.04–
6.92 (m, 1 H).
MS (ES+): m/z (%) = 279.1 (100) [M + H]+.
HRMS (ESI): m/z [M + H+] calcd for C17H15N2O2: 279.1134; found:
279.1134.
13C NMR (75 MHz, MeOH-d4): δ = 166.6, 159.7 (dd, J = 240.3, 2.4 Hz),
153.1, 152.6 (dd, J = 242.5, 2.9 Hz), 149.6, 137.5, 131.85, 127.9 (dd,
J = 14.1, 11.4 Hz), 125.2, 117.4 (dd, J = 22.8, 9.7 Hz), 113.6 (dd, J = 24.5,
7.9 Hz), 113.1 (dd, J = 28.3, 1.6 Hz).
MS (ES+): m/z (%) = 235.1 (100) [M + H]+.
HRMS (ESI): m/z [M + H+] calcd for C12H9N2OF2: 235.0683; found:
3-[(2-Methoxyethoxy)methyl]-N-(4-methoxyphenyl)-3H-imid-
azo[4,5-b]pyridine-6-carboxamide (8)
Starting from 6-bromo-3-[(2-methoxyethoxy)methyl]-3H-imid-
azo[4,5-b]pyridine (184 mg, 0.64 mmol), flash chromatography af-
forded 8 (140 mg, 61%) as a white solid; mp 122 °C.
1H NMR (300 MHz, CDCl3): δ = 8.99 (d, J = 1.4 Hz, 1 H), 8.58 (d, J = 1.2
Hz, 1 H), 8.28 (s, 1 H), 8.24 (s, 1 H), 7.63–7.55 (m, 2 H), 6.96–6.88 (m, 2
H), 5.78 (s, 2 H), 3.83 (s, 3 H), 3.75–3.70 (m, 2 H), 3.53–3.49 (m, 2 H),
3.33 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 164.7, 156.3, 148.4, 145.8, 145.2, 133.7,
131.2, 126.6, 126.4, 122.5, 113.8, 72.9, 71.3, 68.9, 58.8, 55.2.
MS (ES+): m/z (%) = 357.2 (100) [M + H]+.
HRMS (ESI): m/z [M + H+] calcd for C18H21N4O4: 357.1563; found:
235.0685.
N-[3-(Trifluoromethyl)phenyl]nicotinamide (16)
Starting from 3-bromopyridine (100 mg, 0.63 mmol), flash chroma-
tography afforded 16 (126 mg, 74%) as a white solid; mp 149 °C.
1H NMR (300 MHz, MeOH-d4): δ = 9.10 (d, J = 1.6 Hz, 1 H), 8.73 (dd,
J = 4.9, 1.4 Hz, 1 H), 8.41–8.31 (m, 1 H), 8.15 (br s, 1 H), 7.95 (d, J = 8.2
Hz, 1 H), 7.63–7.52 (m, 2 H), 7.45 (d, J = 7.8 Hz, 1 H).
357.1555.
13C NMR (75 MHz, MeOH-d4): δ = 166.5, 153.0, 149.5, 140.6, 137.4,
132.4, 132.2 (q, J = 32.2 Hz), 130.8, 125.5 (q, J = 271.5 Hz), 125.2,
125.1, 122.0 (q, J = 3.9 Hz), 118.4 (q, J = 4.1 Hz).
MS (ES+): m/z (%) = 267.1 (100) [M + H]+.
HRMS (ESI): m/z [M + H+] calcd for C13H10N2OF3: 267.0745; found:
3-[(2-Methoxyethoxy)methyl]-N-(4-methoxyphenyl)-2-{5-[(4-
methoxyphenyl)carbamoyl]pyridin-3-yl}-3H-imidazo[4,5-b]-
pyridine-6-carboxamide (9)
Starting
from
6-bromo-2-(3-bromophenyl)-3-[(2-methoxye-
267.0750.
thoxy)methyl]-3H-imidazo[4,5-b]pyridine (114 mg, 0.26 mmol),
flash chromatography afforded 9 (71 mg, 47%) as a white solid; mp
209 °C.
Ethyl 4-(Nicotinamido)benzoate (17)
Starting from 3-bromopyridine (100 mg, 0.63 mmol), flash chroma-
tography afforded 17 (133 mg, 78%) as a grey solid; mp 125 °C.
1H NMR (300 MHz, DMSO-d6): δ = 10.89 (br s, 1 H), 9.20 (s, 1 H), 8.83
(d, J = 4.2 Hz, 1 H), 8.45 (d, J = 7.9 Hz, 1 H), 7.97 (s, 4 H), 7.69 (dd,
J = 7.8, 5.0 Hz, 1 H), 4.30 (q, J = 7.1 Hz, 2 H), 1.32 (t, J = 7.1 Hz, 3 H).
1H NMR (300 MHz, DMSO-d6): δ = 10.55 (s, 1 H), 10.37 (s, 1 H), 9.38
(d, J = 1.8 Hz, 1 H), 9.31 (d, J = 1.7 Hz, 1 H), 9.05 (d, J = 1.7 Hz, 1 H),
8.95–9.91 (m, 1 H), 8.77 (d, J = 1.7 Hz, 1 H), 7.72 and 7.71 (2d, J = 9.0
Hz, 4 H), 6.97 and 9.96 (2d, J = 9.0 Hz, 4 H), 5.84 (s, 2 H), 3.83–3.78 (m,
2 H), 3.76 (s, 6 H), 3.50–3.45 (m, 2 H), 3.17 (s, 3 H).
13C NMR (75 MHz, DMSO-d6): δ = 165.3, 164.0, 151.0, 147.7, 143.2,
137.2, 130.8, 130.1, 125.0, 124.1, 119.7, 60.5, 14.2.
MS (ES+): m/z (%) = 271.1 (100) [M + H]+.
HRMS (ESI): m/z [M + H+] calcd for C15H15N2O3: 271.1083; found:
13C NMR (75 MHz, MeOH-d4): δ = 163.8, 163.7, 162.9, 162.8, 155.9,
155.7, 153.2, 151.6, 150.2, 150.2, 145.0, 136.0, 133.5, 132.1, 131.8,
130.8, 126.9, 126.7, 125.3, 122.0, 121.9, 113.9, 113.8, 72.0, 70.9, 68.3,
66.7, 66.7, 58.1, 55.2.
MS (ES+): m/z (%) = 583.2 (100) [M + H]+.
HRMS (ESI): m/z [M + H+] calcd for C31H31N6O6: 583.2305; found:
271.1075.
583.2309.
N-(4-Hydroxyphenyl)nicotinamide (20)
Starting from 3-bromopyridine (100 mg, 0.63 mmol), flash chroma-
tography afforded 20 (133 mg, 63%) as a grey solid; mp >250 °C.
N-(4-Bromophenyl)nicotinamide (13)
1H NMR (300 MHz, DMSO-d6): δ = 10.22 (s, 1 H), 9.31 (s, 1 H), 9.08 (d,
J = 1.4 Hz, 1 H), 8.74 (dd, J = 4.7, 1.2 Hz, 1 H), 8.29–8.23 (m, 1 H), 7.59–
7.49 (m, 3 H), 6.79–6.71 (m, 2 H).
Starting from 3-bromopyridine (100 mg, 0.63 mmol), flash chroma-
tography afforded 13 (63 mg, 36%) as a beige solid; mp 174 °C.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2018, 50, A–F